Vanderbilt Ingram Cancer Center Archives
Scalp cooling allows woman to keep hair during chemotherapy
Mar. 8, 2024—Vanderbilt-Ingram Cancer Center has installed a DigniCap Scalp Cooling System last year at its Belle Meade clinic to help prevent hair loss in those going through chemotherapy.
GE HealthCare & Vanderbilt publish data on AI models predicting patient response to immunotherapy
Mar. 5, 2024—The results from a research partnership between GE HealthCare and Vanderbilt University Medical Center utilizing artificial intelligence to enable safer and more precise cancer immunotherapies show that the models they developed predict patient responses with 70% to 80% accuracy.
Study seeks to determine if fallopian tube sonograms can help detect ovarian cancer at early stage
Mar. 1, 2024—Vanderbilt researchers are investigating whether sonograms of fallopian tubes can be effective for the early detection of ovarian cancer, and their ongoing study shows promise.
Fatty acids rewire energy supply chain in stomach cancer development
Jan. 31, 2024—A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer.
Molecular profiles of tissue plus circulating tumor DNA can better guide cancer care
Jan. 22, 2024—Vanderbilt research indicates that adding liquid biopsy testing for circulating tumor DNA mutations increases targetable mutation detection rates.
Chic Awearness supports mentoring program for ovarian cancer patients
Jan. 9, 2024—Chic Awearness is now supporting two new ovarian cancer research initiatives at Vanderbilt University Medical Center and providing matching funding for a social worker to coordinate Woman to Woman, a peer mentoring program launched at VUMC in 2023.
Potential AML therapy induces leukemic stem cell death
Jan. 4, 2024—Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.
Clinical trial shows efficacy for atezolizumab combined with carboplatin
Dec. 15, 2023—by Tom Wilemon Immunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastatic breast cancer. Which patients will benefit the most, however, remains unclear; current biomarkers such as PD-L1 that are used to predict response are mediocre at best. Vanderbilt researchers led a clinical trial combining atezolizumab, an...
Sam S. Chang recognized by the American Urological Association
Dec. 14, 2023—The American Urological Association has announced that Vanderbilt's Sam S. Chang, MD, MBA, is one of its 2024 award recipients.
Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center
Nov. 30, 2023—A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.
Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center
Oct. 26, 2023—Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center earns NCI Merit Award
Oct. 17, 2023—Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.